Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Bonaventure

Showing results (11-20 of 95) with videos related to

Pageof 10
Sort By:
Molecular Pharmacology|October 7, 2004
Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7Changlu Liu, Jingcai Chen, Chester Kuei, et al.
Bioorganic & Medicinal Chemistry Letters|June 13, 2013
The discovery of potent selective NPY Y(2) antagonistsWenying Chai, Victoria D Wong, Diane Nepomuceno, et al.
Frontiers in Neuroscience|March 5, 2014
Orexin-1 receptor blockade dysregulates REM sleep in the presence of orexin-2 receptor antagonismChristine Dugovic, Jonathan E Shelton, Sujin Yun, et al.
Pharmacogenetics and Genomics|May 15, 2007
Genomic and functional conservation of sedative-hypnotic targets in the zebrafishCorinne Renier, Juliette H Faraco, Patrice Bourgin, et al.
Annals of the New York Academy of Sciences|June 16, 2005
Recent progress in relaxin-3-related researchChanglu Liu, Pascal Bonaventure, Steven W Sutton, et al.
Frontiers in Behavioral Neuroscience|February 3, 2015
Selective pharmacological blockade of the 5-HT7 receptor attenuates light and 8-OH-DPAT induced phase shifts of mouse circadian wheel running activityJonathan Shelton, Sujin Yun, Susan Losee Olson, et al.
Neuropharmacology|April 7, 2009
JNJ-10181457, a selective non-imidazole histamine H(3) receptor antagonist, normalizes acetylcholine neurotransmission and has efficacy in translational rat models of cognitionRuggero Galici, Jamin D Boggs, Leah Aluisio, et al.
Frontiers in Pharmacology|April 6, 2019
<i>In vivo</i> Characterization of a Selective, Orally Available, and Brain Penetrant Small Molecule GPR139 AgonistJames R Shoblock, Natalie Welty, Ian Fraser, et al.
Frontiers in Neuroscience|April 12, 2019
GPR139 and Dopamine D2 Receptor Co-express in the Same Cells of the Brain and May Functionally InteractLien Wang, Grace Lee, Chester Kuei, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2010
Novel tetrahydropyrido[3,2-c]pyrroles as 5-HT(7) antagonistsDale A Rudolph, Curt A Dvorak, Lisa Dvorak, et al.
Pageof 10

Showing results (11-20 of 95) with videos related to

Sort By:
Pageof 10
Molecular Pharmacology|October 7, 2004
Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7Changlu Liu, Jingcai Chen, Chester Kuei, et al.
Bioorganic & Medicinal Chemistry Letters|June 13, 2013
The discovery of potent selective NPY Y(2) antagonistsWenying Chai, Victoria D Wong, Diane Nepomuceno, et al.
Frontiers in Neuroscience|March 5, 2014
Orexin-1 receptor blockade dysregulates REM sleep in the presence of orexin-2 receptor antagonismChristine Dugovic, Jonathan E Shelton, Sujin Yun, et al.
Pharmacogenetics and Genomics|May 15, 2007
Genomic and functional conservation of sedative-hypnotic targets in the zebrafishCorinne Renier, Juliette H Faraco, Patrice Bourgin, et al.
Annals of the New York Academy of Sciences|June 16, 2005
Recent progress in relaxin-3-related researchChanglu Liu, Pascal Bonaventure, Steven W Sutton, et al.
Frontiers in Behavioral Neuroscience|February 3, 2015
Selective pharmacological blockade of the 5-HT7 receptor attenuates light and 8-OH-DPAT induced phase shifts of mouse circadian wheel running activityJonathan Shelton, Sujin Yun, Susan Losee Olson, et al.
Neuropharmacology|April 7, 2009
JNJ-10181457, a selective non-imidazole histamine H(3) receptor antagonist, normalizes acetylcholine neurotransmission and has efficacy in translational rat models of cognitionRuggero Galici, Jamin D Boggs, Leah Aluisio, et al.
Frontiers in Pharmacology|April 6, 2019
<i>In vivo</i> Characterization of a Selective, Orally Available, and Brain Penetrant Small Molecule GPR139 AgonistJames R Shoblock, Natalie Welty, Ian Fraser, et al.
Frontiers in Neuroscience|April 12, 2019
GPR139 and Dopamine D2 Receptor Co-express in the Same Cells of the Brain and May Functionally InteractLien Wang, Grace Lee, Chester Kuei, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2010
Novel tetrahydropyrido[3,2-c]pyrroles as 5-HT(7) antagonistsDale A Rudolph, Curt A Dvorak, Lisa Dvorak, et al.
Pageof 10